These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 3254767)

  • 1. Aerosol deposition in the human lung: effect of high-frequency oscillation on the deposition characteristics of an inhaled nebulized aerosol.
    Thomas SH; Langford JA; George RJ; Geddes DM
    Clin Sci (Lond); 1988 Nov; 75(5):535-42. PubMed ID: 3254767
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ventilatory saving by external chest wall compression or oral high-frequency oscillation in normal subjects and those with chronic airflow obstruction.
    George RJ; Winter RJ; Flockton SJ; Geddes DM
    Clin Sci (Lond); 1985 Sep; 69(3):349-59. PubMed ID: 4064575
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oropharyngeal deposition of 3.5 microns particles inhaled through an elongated mouthpiece.
    Svartengren K; Anderson M; Svartengren M; Philipson K; Camner P
    Eur Respir J; 1996 Jul; 9(7):1556-9. PubMed ID: 8836672
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Direct write-out of particle size distribution of inhaled aerosol deposition using a laser scattering method.
    Ishii M; Iijima H; Katsumata U; Shimizu Y; Inoue H; Sasaki H; Takishima T; Ishihara H; Kobayashi T; Ito H
    Respir Physiol; 1989 Oct; 78(1):107-21. PubMed ID: 2813984
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of nebulised aerosol size on lung deposition in patients with mild asthma.
    Clay MM; Clarke SW
    Thorax; 1987 Mar; 42(3):190-4. PubMed ID: 3303427
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Same lung deposited dose in dog dosing a fine and coarse aerosol indicates no difference in intranasal filtration.
    Brülls M; Oag S; Karlsson CA; Lamm Bergström E
    Int J Pharm; 2022 Aug; 624():121977. PubMed ID: 35792234
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparing lung regions of interest in gamma scintigraphy for assessing inhaled therapeutic aerosol deposition.
    Biddiscombe MF; Meah SN; Underwood SR; Usmani OS
    J Aerosol Med Pulm Drug Deliv; 2011 Jun; 24(3):165-73. PubMed ID: 21453048
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Substance deposition assessment in obstructed pulmonary system through numerical characterization of airflow and inhaled particles attributes.
    Lalas A; Nousias S; Kikidis D; Lalos A; Arvanitis G; Sougles C; Moustakas K; Votis K; Verbanck S; Usmani O; Tzovaras D
    BMC Med Inform Decis Mak; 2017 Dec; 17(Suppl 3):173. PubMed ID: 29297393
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Difference in inhaled aerosol deposition patterns in the lungs due to three different sized aerosols.
    Miki M; Isawa T; Teshima T; Anazawa Y; Motomiya M
    Nucl Med Commun; 1992 Jul; 13(7):553-62. PubMed ID: 1495682
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human tracheobronchial deposition and effect of a cholinergic aerosol inhaled by extremely slow inhalations.
    Anderson M; Svartengren M; Camner P
    Exp Lung Res; 1999 Jun; 25(4):335-52. PubMed ID: 10378104
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Variability in the measurement of nebulized aerosol deposition in man.
    Thomas SH; O'Doherty MJ; Page CJ; Nunan TO
    Clin Sci (Lond); 1991 Dec; 81(6):767-75. PubMed ID: 1662583
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Imaging the postdeposition dispersion of an inhaled surfactant aerosol.
    Corcoran TE; Thomas KM; Garoff S; Tilton RD; Przybycien TM; Pilewski JM
    J Aerosol Med Pulm Drug Deliv; 2012 Oct; 25(5):290-6. PubMed ID: 22393908
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Capturing the efficiency of vibrating mesh nebulizers: minimizing upper airway deposition.
    Sagalla RB; Smaldone GC
    J Aerosol Med Pulm Drug Deliv; 2014 Oct; 27(5):341-8. PubMed ID: 25105472
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessing lung deposition of inhaled medications. Consensus statement from a workshop of the British Association for Lung Research, held at the Institute of Biology, London, U.K. on 17 April 1998.
    Snell NJ; Ganderton D
    Respir Med; 1999 Feb; 93(2):123-33. PubMed ID: 10464864
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aerosol deposition in infants with cystic fibrosis.
    Mallol J; Rattray S; Walker G; Cook D; Robertson CF
    Pediatr Pulmonol; 1996 May; 21(5):276-81. PubMed ID: 8726152
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improved efficacy of aerosol delivery to distal airways in pediatric subjects using a new spacer mouth-mask.
    Yüksel H; Berardino L; Yüksel D; Yilmaz O; Burak Z
    Eur Ann Allergy Clin Immunol; 2007 Feb; 39(2):64-8. PubMed ID: 17441418
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oropharyngeal deposition and delivery aspects of metered-dose inhaler aerosols.
    Kim CS; Eldridge MA; Sackner MA
    Am Rev Respir Dis; 1987 Jan; 135(1):157-64. PubMed ID: 3800143
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting aerosol deposition in patients with cystic fibrosis: effects of alterations in particle size and inspiratory flow rate.
    Laube BL; Jashnani R; Dalby RN; Zeitlin PL
    Chest; 2000 Oct; 118(4):1069-76. PubMed ID: 11035679
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nebulized Mannitol, Particle Distribution, and Cough in Idiopathic Pulmonary Fibrosis.
    Kanth PM; Alaienia C; Smaldone GC
    Respir Care; 2018 Nov; 63(11):1407-1412. PubMed ID: 30154129
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aerosol delivery of nebulised budesonide in young children with asthma.
    Schueepp KG; Devadason SG; Roller C; Minocchieri S; Moeller A; Hamacher J; Wildhaber JH
    Respir Med; 2009 Nov; 103(11):1738-45. PubMed ID: 19540100
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.